The cost of nationwide nucleic acid testing is very high. In a city with a population of 10 million, the cost of carrying out nucleic acid testing for all employees is about 60 to 70 million, and about 200 million for three consecutive days.

The cost of nationwide nucleic acid testing is very high, and it is impossible to estimate specific figures. In order to pay for nucleic acid testing, local finances need to bear huge pressure.

In order to increase the enthusiasm of the people to participate in nucleic acid testing, most places provide free testing, and the funds for nucleic acid testing are borne by local finance.

When all employees are tested for nucleic acid, not only nucleic acid equipment is needed, but also subsidies for testing personnel, material costs, and testing fees. These costs are evenly distributed to everyone, which is about six or seven yuan.

The country now has clear regulations on the fees for nucleic acid testing. For single-tube testing, the maximum fee cannot exceed 16 yuan, and for mixed-tube testing, the maximum fee cannot exceed 5 yuan.

The nucleic acid tests we usually participate in are all mixed-tube tests. Based on these figures, we can calculate the direct cost of nucleic acid testing for the entire population, which is the cost incurred by the usual use of nucleic acid equipment.

However, these costs do not include the wages of nucleic acid samplers and nucleic acid testing equipment, so a real nucleic acid test cannot be completed by paying 5 yuan per person.

The cost of universal nucleic acid testing is very high, and it is a huge expenditure. If we insist on doing universal nucleic acid testing for a long time, the local finance will simply not be able to afford it.

In response to the epidemic, many places have begun to change their nucleic acid testing policies, requiring residents to participate in nucleic acid testing at their own expense. This can alleviate local financial pressure, ensure the smooth progress of nucleic acid testing, and prevent large-scale outbreaks of the epidemic.

Some places want to use medical insurance funds to pay for universal nucleic acid testing, but the National Medical Insurance Administration does not support this approach and has clearly issued a document not allowing the use of medical insurance funds.

Because the medical insurance fund is like a tax, it has a special financial account, and it must be earmarked for nucleic acid testing for epidemic prevention and control, which does not meet the conditions for medical insurance expenditures.

If the medical insurance fund is used to pay for large-scale nucleic acid testing, it will lead to a serious shortage of medical insurance funds. In the future, when someone gets sick again and needs to be reimbursed, they will encounter many difficulties.